Skip to main content

16 Result(s)

within U. Krug Remove this filter

and

  1. No Access

    Article

    Symptom- und Belastungserfassung mit MIDOS oder IPOS – Kennzahl Symptom- und Bedarfserfassung, KeSBa-Projekt

    Servet Para, A. Letsch, B. Alt-Ep**, D. Wecht, M. Naegele, M. Meßmann, U. Krug… in Forum (2022)

  2. No Access

    Article

    Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia

    We randomized 3375 adults with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome to test whether increasingly intensive chemotherapies assigned at study-entry and analyzed on a...

    U Krug, W E Berdel, R P Gale, C Haferlach, S Schnittger, C Müller-Tidow… in Leukemia (2016)

  3. No Access

    Article

    Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia

    DNA methylation changes are a constant feature of acute myeloid leukemia. Hypomethylating drugs such as azacitidine are active in acute myeloid leukemia (AML) as monotherapy. Azacitidine monotherapy is not cur...

    C Müller-Tidow, P Tschanter, C Röllig, C Thiede, A Koschmieder, M Stelljes… in Leukemia (2016)

  4. No Access

    Article

    Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT

    Non-relapse mortality after Allo-SCT has significantly decreased over the last years. Nevertheless, relapse remains a major cause for post SCT mortality in patients with AML and high-risk myelodysplastic syndr...

    T Sauer, G Silling, C Groth, F Rosenow, U Krug, D Görlich… in Bone Marrow Transplantation (2015)

  5. No Access

    Article

    CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT

    After allo-SCT, analysis of CD34+ lineage-specific donor cell chimerism (DCC) is a sensitive method for monitoring minimal residual disease in patients with AML or myelodysplastic syndrome (MDS) with CD34 express...

    F Rosenow, A Berkemeier, U Krug, C Müller-Tidow, J Gerss… in Bone Marrow Transplantation (2013)

  6. No Access

    Article

    High-dose chemotherapy with autologous PBSC transplantation for poor prognosis germ cell tumors: a retrospective monocenter analysis of 44 cases

    Germ cell cancer (GCC) is curable in metastatic stages. The International Germ Cell Cancer Collaborative Group (IGCCCG) reports a poor prognosis subgroup with a 5-year survival of 48%. High-dose chemotherapy w...

    M Mohr, I Hartig, T Kessler, C Hamisch, S Kliesch, U Krug… in Bone Marrow Transplantation (2012)

  7. No Access

    Article

    Die Primärtherapie des nichtkleinzelligen Lungenkarzinoms

    Das Lungenkarzinom ist die häufigste zum Tode führende Tumorerkrankung. Nichtkleinzellige Lungenkarzinome („non-small cell lung cancer“; NSCLC) machen ca.70–80% der Lungenkarzinome aus. In Abhängigkeit vom Tum...

    Dr. M. Mohr, T. Kessler, U. Krug… in Zeitschrift für Herz-,Thorax- und Gefäßchi… (2010)

  8. No Access

    Article

    The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML

    Recently, mutations in the transcription factor CCAAT/ enhancer binding protein alpha (C/EBPα) have been described in acute myeloid leukemia (AML). We performed a mutational analysis of the C/EBPα gene in the ...

    A Kaeferstein, U Krug, J Tiesmeier, M Aivado, M Faulhaber, M Stadler, J Krauter… in Leukemia (2003)

  9. No Access

    Chapter and Conference Paper

    Real-Time RT-PCR for the Detection and Quantification of AML1/MTG8 Fusion Transcripts in Patients with t(8;21) Positive AML

    AML1/MTG8 was quantified relative to the expression of the GAPDH housekee** gene by real-time RT-PCR in 22 patients with t(8;21) positive AML at initial diagnosis and in seven of these patients also during/a...

    J. Krauter, M. P. Wattjes, S. Nagel, O. Heidenreich, U. Krug… in Acute Leukemias VIII (2001)

  10. No Access

    Chapter and Conference Paper

    Rasterelektronenmikroskopische (REM) und Transmissionselektronenmikroskopische (TEM) Untersuchungen der Keratitis Herpetica Dendritica

    Das Abradat einer an Keratitis dendritica erkrankten menschlichen Hornhaut wird zunächst mit dem Rasterelektronenmikroskop (REM) untersucht. Der Befund ergibt einen Einblick in die Pathogenese der Erkrankung. ...

    Dr. H. Conrads, R. Blaschke, U. Krug in Uveitis (1981)

  11. No Access

    Article

    Unreifzellige myeloische Leukämie

    Die klinischen Befunde von 14 Patienten mit unreifzelliger myeloischer Leukämie werden in knapper Form mitgeteilt. An den leukämischen Zellen (Myeloblasten, Promyelozyten) wurden folgende Untersuchungen durchg...

    D. Huhn, F. Schmalzl, U. Krug in Blut (1971)

  12. No Access

    Article

    Referate

    Walther Stich, D. Schmidt, Susanna R. Hollán, H. G. Arlt, U. Krug, M. Eulitz in Blut (1971)

  13. No Access

    Article

    Buchbesprechungen

    W. Spielmann, W. Stich, U. Krug, F. Scheiffarth, W. Mempel, D. Huhn in Blut (1970)

  14. No Access

    Article

    Referate

    U. Krug, E. Krug in Blut (1970)

  15. No Access

    Article

    Referate

    U. Krug, P. Dörmer, H. H. v. Albert, D. Huhn in Blut (1970)

  16. No Access

    Article

    Buchbesprechungen

    P. Dörmer, R. Marx, U. Krug in Blut (1970)